1. Home
  2. AUPH vs BBSI Comparison

AUPH vs BBSI Comparison

Compare AUPH & BBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • BBSI
  • Stock Information
  • Founded
  • AUPH 1993
  • BBSI 1965
  • Country
  • AUPH Canada
  • BBSI United States
  • Employees
  • AUPH N/A
  • BBSI N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • BBSI Professional Services
  • Sector
  • AUPH Health Care
  • BBSI Consumer Discretionary
  • Exchange
  • AUPH Nasdaq
  • BBSI Nasdaq
  • Market Cap
  • AUPH 999.8M
  • BBSI 1.1B
  • IPO Year
  • AUPH 1999
  • BBSI 1993
  • Fundamental
  • Price
  • AUPH $8.09
  • BBSI $40.35
  • Analyst Decision
  • AUPH Strong Buy
  • BBSI Buy
  • Analyst Count
  • AUPH 2
  • BBSI 3
  • Target Price
  • AUPH $11.50
  • BBSI $41.67
  • AVG Volume (30 Days)
  • AUPH 1.3M
  • BBSI 163.1K
  • Earning Date
  • AUPH 05-05-2025
  • BBSI 04-30-2025
  • Dividend Yield
  • AUPH N/A
  • BBSI 0.80%
  • EPS Growth
  • AUPH N/A
  • BBSI 7.03
  • EPS
  • AUPH 0.04
  • BBSI 1.98
  • Revenue
  • AUPH $235,133,000.00
  • BBSI $1,144,531,000.00
  • Revenue This Year
  • AUPH $11.86
  • BBSI $9.83
  • Revenue Next Year
  • AUPH $24.96
  • BBSI $7.40
  • P/E Ratio
  • AUPH $197.25
  • BBSI $20.26
  • Revenue Growth
  • AUPH 33.97
  • BBSI 7.04
  • 52 Week Low
  • AUPH $4.77
  • BBSI $28.42
  • 52 Week High
  • AUPH $10.67
  • BBSI $44.97
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 54.42
  • BBSI 50.43
  • Support Level
  • AUPH $7.59
  • BBSI $38.93
  • Resistance Level
  • AUPH $7.83
  • BBSI $40.86
  • Average True Range (ATR)
  • AUPH 0.34
  • BBSI 1.37
  • MACD
  • AUPH 0.04
  • BBSI 0.04
  • Stochastic Oscillator
  • AUPH 84.90
  • BBSI 81.18

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

About BBSI Barrett Business Services Inc.

Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.

Share on Social Networks: